Amsbio Introduces Synthetic Cell Mimics for Flow Cytometry
Amsbio has launched synthetic cell mimic controls for flow cytometry, aiming to improve lot-to-lot consistency and reproducibility in diagnostics and cell therapy manufacturing.
Amsbio has launched synthetic cell mimic controls for flow cytometry, aiming to improve lot-to-lot consistency and reproducibility in diagnostics and cell therapy manufacturing.
Glut1 deficiency syndrome, or De Vivo Disease, is a rare and disabling neurological disease still relatively unknown to the medical community. And many are unaware that a simple blood test can now be used to diagnose it.
The new European In Vitro Diagnostic Regulation is currently set to take effect in May 2022 and replaces the In Vitro Diagnostics Directive.
The new range of recombinant monoclonal antibodies is directed against the three main mouse isotypes: IgG1, IgG2a, and IgG2b.
Read MoreThe automated sample preparation unit is linked to a clinical flow cytometer, creating a fully integrated sample-to-answer flow cytometry solution.
Read MoreKRC will develop a custom microfluidic module to support UC Davis research on label-free flow cytometry.
Read MoreThe recombinant antibodies do not display mixtures of heavy and light immunoglobulin chains.
Read MoreThe dyes allow swift discrimination between live and apoptotic or dead cells by flow cytometry.
Read MoreLab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Read MoreFlowMetric Diagnostics and Handyem have partnered to develop a mobile point-of-care diagnostic laboratory based on flow cytometry capabilities.
Read MoreWhen stained with fluorescent antibodies and analyzed by flow cytometry, the control provides reference values for abnormal cells often found in certain types of hematopoietic neoplasms.
Read MoreThe Binding Site, a specialist protein company based in the United Kingdom, and eBioscience, an Affymetrix business, have announced a multiyear distribution agreement granting the Binding Site exclusive rights to distribute eBioscience’s analyte-specific reagents and CE-marked clinical flow cytometry reagents to hospitals and reference labs.
Read MoreBeckman Coulter Life Sciences’ Navios flow cytometry system has just received FDA approval for in vitro diagnostic use.
Read MoreStreck today announces the introduction of CD4 Count, a new whole blood quality control for verifying the accuracy of the BD FACSCount flow cytometer.
Read MoreDNA-Purification Kit Enables high yields of total DNA Qiagen Inc has developed DNeasy® blood and tissue kits for DNA purification from animal samples in spin-column and 96-well-plate formats. Protocols for spe
Read MoreBy Wayne Ryan, PhD, and Dominic Warrino, PhD As every laboratory professional knows, reliable results begin with reliable samples, and nowhere is this more evident than in today’s flow cytometry lab. Flow cytometry is used to determine the t
Read MoreBecton, Dickinson and Co (BD), through its BD Biosciences segment has announced the US clearance and release of the BD FACSCanto™ flow cytometer for in vitro diagnostic use. This new benchtop analyzer now supports not only life science and cl
Read MoreBy Lori Weeks, CLT2 Lori Weeks uses Cyto-Chex to preserve specimens at OSF St. Francis Medical Center. In early 2000, our flow cytometry lab at OSF St. Francis Medical Center in Peoria, Ill, found itself facing a dilemma that is all too common i
Read More